Highlights of the Conference
- Immunomodulatory Antibodies
- Bispecific Antibodies
- Immuno-Oncology Targets
- Combination Immunotherapy
- Preclinical & Translational IO
- Personalized Cancer Vaccines
- IO Biomarkers 1: Immune Profiling and Immune Monitoring
- IO Biomarkers 2: Predictive Biomarkers and Companion Diagnostics
- Neoantigen Targeted Therapies
- Oncolytic Virus Immunotherapy
- Adoptive T Cell Therapy 1: Discovery
- Adoptive T Cell Therapy 1: Development
- Evaluating response in Immunotherapy
- Toxicity management of Immunotherapy drugs
- Stem cell transplant
- Case based panel discussion
- Immuno-Oncology Consensus Guidelines
